Conference Coverage: EHA 2022 – Focus on Lymphoma

Lymphoma-specific discussions on latest research updates, therapeutic advances, and their application in clinical decision-making.

June 16, 2022
Purchase Report

FACULTY CHAIR

Brad S. Kahl, MD

Washington University School of Medicine, St. Louis, MO, USA

Faculty Members

TBC

REPORT SNAPSHOT

  • Advances in DLBCL/Aggressive B-Cell Lymphoma
  • Advances in CAR T
  • Advances in FL
  • Advances in MCL and MZL
  • Evolving Use of BTK Inhibitors in CLL
  • Role of Fixed-Duration and MRD-Guided Strategies in CLL

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.